Yunnan Biovalley Pharmaceutical Co (BJSE:920266) E10: ¥0.00 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BJSE:920266 Yunnan Biovalley Pharmaceutical Co Ltd BJSE:920266
66 GF Score
Price ¥7.35
GF Value ¥7.81
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Yunnan Biovalley Pharmaceutical Co E10?

Yunnan Biovalley Pharmaceutical Co BJSE:920266 66 E10 is ¥0.00 as of Jun. 2026. GuruFocus rates BJSE:920266 with a GF Score™ of 66/100 and a GF Value™ of ¥7.81 (Fairly Valued). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Yunnan Biovalley Pharmaceutical Co's adjusted earnings per share data for the three months ended in Jun. 2026 was ¥0.000. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ¥0.00 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Yunnan Biovalley Pharmaceutical Co's average E10 Growth Rate was -100.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-08-25), Yunnan Biovalley Pharmaceutical Co's current stock price is ¥7.35. Yunnan Biovalley Pharmaceutical Co's E10 for the quarter that ended in Jun. 2026 was ¥0.00. Yunnan Biovalley Pharmaceutical Co's Shiller PE Ratio of today is .

During the past 13 years, the highest Shiller PE Ratio of Yunnan Biovalley Pharmaceutical Co was 55.96. The lowest was 29.62. And the median was 41.64.


Yunnan Biovalley Pharmaceutical Co  (BJSE:920266) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

During the past 13 years, the highest Shiller P/E Ratio of Yunnan Biovalley Pharmaceutical Co was 55.96. The lowest was 29.62. And the median was 41.64.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Yunnan Biovalley Pharmaceutical Co E10 Related Terms


Yunnan Biovalley Pharmaceutical Co E10 Historical Data

* Premium members only.

The historical data trend for Yunnan Biovalley Pharmaceutical Co's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Yunnan Biovalley Pharmaceutical Co E10 Chart

Yunnan Biovalley Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.22

Yunnan Biovalley Pharmaceutical Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.25 0.24 0.22 0.21 0.00

BJSE:920266 vs ZTS: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Yunnan Biovalley Pharmaceutical Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Yunnan Biovalley Pharmaceutical Co Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Yunnan Biovalley Pharmaceutical Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Yunnan Biovalley Pharmaceutical Co's Shiller PE Ratio falls into.


BJSE:920266
66GF Score
Yunnan Biovalley Pharmaceutical Co Ltd BJSE:920266
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Yunnan Biovalley Pharmaceutical Co E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Yunnan Biovalley Pharmaceutical Co's adjusted earnings per share data for the three months ended in Jun. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0/116.0564*116.0564
=0.000

Current CPI (Jun. 2026) = 116.0564.

Yunnan Biovalley Pharmaceutical Co Quarterly Data

per share eps CPI Adj_EPS
201606 0.000 101.400 0.000
201612 0.000 102.600 0.000
201703 0.050 103.200 0.056
201706 0.370 103.100 0.416
201709 0.170 104.100 0.190
201712 0.060 104.500 0.067
201803 0.050 105.300 0.055
201806 0.140 104.900 0.155
201809 0.100 106.600 0.109
201812 0.310 106.500 0.338
201903 0.070 107.700 0.075
201906 0.140 107.700 0.151
201909 0.110 109.800 0.116
201912 0.430 111.200 0.449
202003 -0.080 112.300 -0.083
202006 0.320 110.400 0.336
202009 0.010 111.700 0.010
202012 0.370 111.500 0.385
202103 -0.050 112.662 -0.052
202106 0.254 111.769 0.264
202109 0.150 112.215 0.155
202112 0.310 113.108 0.318
202203 -0.003 114.335 -0.003
202206 0.048 114.558 0.049
202209 0.070 115.339 0.070
202212 -0.500 115.116 -0.504
202303 0.010 115.116 0.010
202306 -0.045 114.558 -0.046
202309 0.080 115.339 0.080
202312 -0.150 114.781 -0.152
202403 0.080 115.227 0.081
202406 -0.046 114.781 -0.047
202409 -0.024 115.785 -0.024
202412 -0.614 114.893 -0.620
202503 -0.140 115.116 -0.141
202506 -0.093 114.907 -0.094
202509 -0.060 115.471 -0.060
202512 -0.130 115.832 -0.130
202603 -0.040 116.303 -0.040
202606 0.000 116.056 0.000

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of ¥0.00 mean?
Yunnan Biovalley Pharmaceutical Co (BJSE:920266) has a E10 of ¥0.00 as of Jun. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Yunnan Biovalley Pharmaceutical Co and its competitors.
Is Yunnan Biovalley Pharmaceutical Co's E10 too high?
Yunnan Biovalley Pharmaceutical Co's current E10 is ¥0.00. Overall, Yunnan Biovalley Pharmaceutical Co has a GF Score™ of 66/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Yunnan Biovalley Pharmaceutical Co's E10 compare to ZTS?
Yunnan Biovalley Pharmaceutical Co's E10 of ¥0.00 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Yunnan Biovalley Pharmaceutical Co and its competitors. Yunnan Biovalley Pharmaceutical Co's current E10 is ¥0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Yunnan Biovalley Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Yunnan Biovalley Pharmaceutical Co (BJSE:920266) is currently considered Fairly Valued. The stock's GF Value™ is ¥7.81, compared to a current price of ¥7.35 — trading 5.9% below its estimated fair value. The current E10 is ¥0.00. Yunnan Biovalley Pharmaceutical Co's overall GF Score™ is 66/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Yunnan Biovalley Pharmaceutical Co (BJSE:920266), the current E10 is ¥0.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Yunnan Biovalley Pharmaceutical Co (BJSE:920266) Overvalued in 2026?

Based on GuruFocus' analysis, Yunnan Biovalley Pharmaceutical Co stock appears to be undervalued. The current stock price of ¥7.35 is trading 5.9% below its estimated GF Value™ of ¥7.81. GuruFocus considers Yunnan Biovalley Pharmaceutical Co to be Fairly Valued.

Key valuation signals for BJSE:920266:

  • E10: ¥0.00
  • GF Value™: ¥7.81 vs. price of ¥7.35 (5.9% below fair value)
  • GF Score™: 66/100 with 3 warning signs

No single metric tells the full story. See the BJSE:920266 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Yunnan Biovalley Pharmaceutical Co Business Description

Address No. 999 Biological Valley Street, Majinpu New District, High-tech Zone, Yunnan Province, Kunming City, CHN, 650500
Yunnan Biovalley Pharmaceutical Co Ltd engages in research and development, production, and marketing of pharmaceuticals and health care based on herbal medicines. The products on the market include breviscapine injection, breviscapine Shengmai capsules, breviscapine tablets, breviscapine dripping pills, Erigeron Capsules, Erigeron Soft Capsules.
66GF Score

Get the complete analysis for BJSE:920266

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥7.35
Price
¥7.81
GF Value